EQS-Adhoc: Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition
Werte in diesem Artikel
|
EQS-Ad-hoc: Merck KGaA / Key word(s): Takeover Werbung Werbung Darmstadt, February 10, 2025 – Merck KGaA (“Merck”) reacts to press reports and confirms advanced discussions with Springworks Therapeutics, Inc. Merck also confirms that no legally binding agreement has been entered into. There is no certainty that any transaction will materialize. Furthermore, critical conditions have yet to be met.
End of inside information Contact Merck KGaA Dr. Gangolf Schrimpf Merck KGaA Frankfurter Straße 250 64293 Darmstadt Germany Phone: +49 6151 729591 Email: gangolf.schrimpf@merckgroup.com Internet: https://www.merckgroup.com/ ISIN: DE0006599905 WKN: 659990 Indices: DAX Stock exchanges: Regulated Market of Frankfurt am Main (Prime Standard); Open Markets of Berlin, Düsseldorf, Hamburg, Hanover, Munich, Stuttgart; EUREX derivatives exchange; London, SIX End of Inside Information
10-Feb-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Werbung Werbung |
| Language: | English |
| Company: | Merck KGaA |
| Frankfurter Str. 250 | |
| 64293 Darmstadt | |
| Germany | |
| Phone: | +49 (0)6151 72 - 2702 |
| E-mail: | insiderregister@merckgroup.com |
| Internet: | https://www.merckgroup.com/de |
| ISIN: | DE0006599905 |
| WKN: | 659990 |
| Indices: | DAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; London, SIX |
| EQS News ID: | 2084015 |
| End of Announcement | EQS News Service |
|
|
2084015 10-Feb-2025 CET/CEST
Ausgewählte Hebelprodukte auf Merck
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Merck
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Nachrichten zu Merck KGaA
Analysen zu Merck KGaA
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.02.2025 | Merck Overweight | JP Morgan Chase & Co. | |
| 10.02.2025 | Merck Buy | Goldman Sachs Group Inc. | |
| 07.02.2025 | Merck Overweight | JP Morgan Chase & Co. | |
| 31.01.2025 | Merck Buy | Deutsche Bank AG | |
| 20.01.2025 | Merck Overweight | JP Morgan Chase & Co. |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.02.2025 | Merck Overweight | JP Morgan Chase & Co. | |
| 10.02.2025 | Merck Buy | Goldman Sachs Group Inc. | |
| 07.02.2025 | Merck Overweight | JP Morgan Chase & Co. | |
| 31.01.2025 | Merck Buy | Deutsche Bank AG | |
| 20.01.2025 | Merck Overweight | JP Morgan Chase & Co. |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.01.2025 | Merck Market-Perform | Bernstein Research | |
| 18.10.2024 | Merck Market-Perform | Bernstein Research | |
| 29.07.2024 | Merck Market-Perform | Bernstein Research | |
| 25.06.2024 | Merck Market-Perform | Bernstein Research | |
| 06.12.2023 | Merck Halten | DZ BANK |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.03.2023 | Merck Verkaufen | DZ BANK | |
| 02.03.2023 | Merck Sell | Goldman Sachs Group Inc. | |
| 07.02.2023 | Merck Sell | Goldman Sachs Group Inc. | |
| 02.02.2023 | Merck Verkaufen | DZ BANK | |
| 15.11.2022 | Merck Sell | Goldman Sachs Group Inc. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Merck KGaA nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen